WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF ANTIDIABETIC DRUGS ALOGLIPTIN BENZOATE AND PIOGLITAZONE HCL IN PHARMACEUTICAL FORMULATION

Khushabu R. Patil*, Dr. Tushar A. Deshmukh and Dr. Vijay R. Patil

ABSTRACT

A simple reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for simultaneous determination of alogliptin benzoate and pioglitazone HCl in bulk and tablet dosage form. Chromatographic analysis was performed on Cosmosil C18 column (150 x 4.6 mm, 5μm) with a mixture of Acetonitrile: 10 mM potassium dihydrogen phosphate (pH 2.5 adjusted with ortho phosphoric acid) (30:70 v/v) as mobile phase, at a flow rate of 1.0 ml/min. UV detection was performed at 230 nm. The method was validated according to ICH guidelines. The retention times of alogliptin benzoate and pioglitazone HCl were 6.24 ± 1.26 and 2.33 ± 1.37 min, respectively. Calibration plots were linear over the concentration ranges 10-50 μg/ml μg/ml and 5-25 μg/ml for alogliptin benzoate and pioglitazone HCl respectively. The Limits of detection were 0. 38 μg/ml and 0. 09 μg/ml and the quantification limit were 1.17 μg/ml and 0.27 μg/ml for alogliptin benzoate and pioglitazone HCl respectively. The assay was found to be 99.98 ± 0.17and 100.14 ± 0.28.

Keywords: Pioglitazone HCl, Alogliptin Benzoate, RP-HPLC, Validation.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More